Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.05 | 1.67 |
NAV | ₹17.86 | ₹214.64 |
Fund Started | 27 Jan 2023 | 20 Aug 2004 |
Fund Size | ₹1287.64 Cr | ₹15520.74 Cr |
Exit Load | Exit load of 1%, if redeemed within 12 months. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 27.37% | 25.48% |
3 Year | - | 24.74% |
5 Year | - | 22.70% |
1 Year
3 Year
5 Year
Equity | 98.05% | 83.32% |
Cash | 1.95% | 16.35% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 4.12% |
Reliance Industries Ltd. | 3.53% |
ICICI Bank Ltd. | 3.17% |
ITC Ltd. | 2.72% |
VA Tech Wabag Ltd. | 2.38% |
Bharti Airtel Ltd. | 2.27% |
Larsen & Toubro Ltd. | 2.02% |
Infosys Ltd. | 1.94% |
Oracle Financial Services Software Ltd. | 1.88% |
Tata Consultancy Services Ltd. | 1.88% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.49% |
ICICI Bank Ltd. | 9.21% |
Axis Bank Ltd. | 8.35% |
Maruti Suzuki India Ltd. | 4.46% |
SBI Life Insurance Company Ltd. | 4.17% |
Cipla Ltd. | 4.15% |
Kotak Mahindra Bank Ltd. | 3.98% |
HCL Technologies Ltd. | 3.81% |
Bharti Airtel Ltd. | 3.67% |
Piramal Pharma Ltd. | 3.64% |
Name | Dhimant Shah | Dhruv Muchhal |
Start Date | 01 Dec 2022 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation from a diversified portfolio that dynamically invests in equity and equity-related securities of companies across various market capitalisation. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 27 Jan 2023 | 20 Aug 2004 |
Description
Launch Date